The KCl cotransporter (KCC) plays a significant role in the ionic and osmotic homeostasis of many cell types. Four KCC isoforms have been cloned. KCC1 and KCC4 activity is osmolality-sensitive and involved in volume regulation. KCC2, a neuronal-specific isoform, can lower intracellular Cl ؊ and is critical for inhibitory GABA responses in the mature central nervous system. KCC3, initially cloned from vascular endothelial cells, is widely but not universally distributed and has an unknown physiological significance. Here we show a tight link between the expression and activity of KCC3 and cell growth by a NIH͞3T3 fibroblast expression system. KCC3 activity is sensitive to [(dihydroindenyl)oxy] alkanoic acid (DIOA) and N-ethylmaleimide and is regulated by tyrosine phosphorylation. Osmotic swelling does not activate KCC3, and the process of regulatory volume decrease is refractory to DIOA, indicating that KCC3 is not involved in volume regulation. KCC3 expression enhances cell proliferation, and this growth advantage can be abolished by the inhibition of KCC3 by DIOA. Fluorescence-activated cell sorting measurements and Western blot analysis show DIOA caused a significant reduction of the cell fraction in proliferative phase and a change in phosphorylation of retinoblastoma protein (Rb) and cdc2, suggesting that KCC3 activity is important for cell cycle progression. Insulin-like growth factor-1 up-regulates KCC3 expression and stimulates cell growth. Tumor necrotic factor-␣ down-regulates KCC3 expression and causes growth arrest. These data indicate that KCC3 is an important KCC isoform that may be involved in cell proliferation.
T
he KCl cotransporter (KCC) has been implicated not only in regulatory volume decrease but also in transepithelial salt absorption, renal K ϩ secretion, myocardial K ϩ loss during ischemia, and regulation of neuronal Cl Ϫ concentrations (1-3). A major advance in the understanding of KCC has been the recent identification of genes that encode four KCC isoforms. KCC1 is a ''housekeeping'' isoform for cell volume regulation (4) . KCC2, a neuronal-specific isoform, by lowering intracellular Cl Ϫ , is critical for inhibitory GABA responses in the mature central nervous system (5, 6) . The KCC3 gene is located on chromosome 15q13, which colocalizes with the gene for myoclonal epilepsy, and the mRNA of KCC3 has been found in vascular endothelial cells, heart, kidney, brain, placenta, liver, and lung (7) (8) (9) . Despite the wide distribution of KCC3, next to nothing is known about the functional and regulatory properties of this isoform. KCC4, predominantly found in heart and kidney, is volume-sensitive and also contributes to volume regulation (9, 10) .
The present study was aimed at characterizing the regulation and function of the recently cloned human KCC3 by using the NIH͞3T3 fibroblast expression system. NIH͞3T3 cells, which, unlike many other cell types [such as human embryonic kidney (HEK)-293 cells and Xenopus oocytes], do not have endogenous KCC activity and therefore provide a suitable system for expression. We demonstrate that KCC3 plays an important role in the regulation of cell growth.
Materials and Methods
Cell Culture, Transfection, and Treatment. The NIH͞3T3 7-4 cell line (11) (12) (13) , derived from mouse NIH͞3T3 fibroblasts, was used to study KCC3 function. This cell line contains an inducible Ha-ras Val12 oncogene, regulated by the Escherichia coli lac operator͞repressor system (11, 14) . The full-length KCC3 cDNA construct was subcloned into the eukaryotic expression vector pCDNA3.1 (Invitrogen). Plasmids were transfected into NIH͞ 3T3 7-4 cells by lipofection (11, 12) . Cells transfected with empty vector were the control. To assess proliferation, cells were plated at the density of 10 5 per dish on 60-mm dishes and the medium changed every 2 days. Counts were performed with the aid of a hemocytometer by using trypan blue exclusion (0.08%) to monitor viability. The parental NIH͞3T3 7-4 cells contain plasmids pSVlacOras and p3ЈSS (14) , in which the expression of Ha-ras can become doubly induced by a nonmetabolizable lactose analogue, isopropyl-␤-D-thiogalactoside (IPTG) (11, 12) . In our preliminary results, the NIH͞3T3 7-4 cells with stable KCC3 transfection still reserve the characteristic of IPTGinduced ras overexpression.
Reverse Transcriptase-PCR (RT-PCR).
Total RNAs were isolated by RNeasy Mini Kit (Qiagen, Chatsworth, CA). After annealing 5 g of total RNA with oligo(dT), cDNA was prepared with Superscript II (Life Technologies, Gaithersburg, MD). Two oligonucleotide primer pairs were synthesized over regions specific for the human KCC3 cDNA. For the first primer pair, forward (5Ј-GGAAGTAACATGGCACTTTTCG-3Ј) and reverse (5Ј-CAGGGCCATGAGCACGAGCGTG-3Ј) primers were used to amplify a 597-bp fragment from KCC3 (hKCC3: nucleotides 200-796). For the second primer pair, forward (5Ј-CTATCCT TGCCATCCTGACC-3Ј) and reverse (5Ј-GCAGCAGTTGTCACTCGAAC-3Ј) primers were used to amplify a 1,099-bp fragment from KCC3 (hKCC3: nucleotides 1723-2821). The positive control was total RNA isolated from the human cervical cancer SiHa cell line (15) . PCR was carried out as described in detail elsewhere (15) . Briefly, after the reaction contents were heated for 3 min at 94°C, 30 cycles of PCR were performed (each consisting of incubation of 30 sec at 94°C, 30 sec at 55°C, and 1 min at 72°C). To assess the possibility of differential expression of KCC3 mRNA under different culture conditions, semiquantitative RT-PCR techniques with ␤-actin as the internal standard were used (15) . This paper was submitted directly (Track II) to the PNAS office.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. propidium iodide for at least 30 min. For each cell population, 10,000 cells were analyzed by FACS and the proportion in G 0 ͞G 1 , S and G 2 ͞M phases estimated by using the MODFIT cell cycle analysis program (Ver. 2.0, Verity Software House, Topsham, ME). Cells were classified as in G 0 ͞G 1 , G 2 ͞M, and S phase from the fluorescence intensity (16) .
Measurements of Cell Volume and Intracellular Cl ؊ Content. Cell volume was measured at room temperature as described previously (17) (18) (19) . Briefly, cells were harvested and transferred to Petri dishes to achieve cell attachment for Ϸ30 min. Then isotonic solution or hypotonic solution with or without the chemical tested at room temperature was superfused at 2 ml⅐min Ϫ1 . Cells were viewed by an Olympus IX70 inverted microscope equipped with Hoffman modulation optics (Olympus, Tokyo). To monitor the change of cell size, the microscope was coupled to a video camera system, and the images were recorded in real time and analyzed by the public domain NIH IMAGE program. The majority of cells observed were spheroid, and the relative volume change (V͞Vo) was calculated from the cross-sectional surface area at the beginning (So) and during (S) the experiments from the relation: The cell suspensions were then centrifuged through a mixture of Mazola corn oil and dibutylphthalate (3:10). The pellet was extracted with 2% SDS, and the radioactivity was determined by liquid scintillation counting.
Western Immunoblotting for Cell Cycle Analysis. Cells from different culture conditions were harvested on ice with protein sample buffer. Protein concentrations were determined with a Bio-Rad protein assay. Equal amounts of proteins were separated by 10% SDS͞PAGE and transferred to polyvinylidene difluoride (Stratagene) membranes. Extracts were tested for the expression of selected cell cycle-related proteins by the following antibodies: phospho-retinoblastoma protein (Rb) (Ser-795) and phosphocdc2 (Tyr-15) (Cell Signaling Technology, Beverly, MA). All Western blots first probed with the phospho-specific antibodies were stripped and reprobed with ␤-actin antibody (Amersham Pharmacia) as an internal standard. Phosphorylated levels were analyzed by scanning densitometry, and the results were expressed as arbitrary units.
Results
To study the cellular and molecular mechanisms underlying KCC3 regulation, we developed KCC3 expression in the NIH͞ 3T3 7-4 cell line stably transfected with human KCC3 cDNA. To estimate the expression of the KCC3 gene, mRNA was isolated from parental, mock-transfected (transfected with empty vector), and transfected cells. By using specific KCC3 primers, the RT-PCR results reveal that mRNA transcripts of KCC3 were present in transfected cells but not in either the parental cells or cells after mock transfection (Fig. 1A) .
KCC activity was subsequently studied in these cells by using Fig. 1 B and C) . In parental and mock-transfected cells, the K Fig. 1 B and C) . The KCC3 isoform is therefore the only O-and B-insensitive Cl was used to replace Cl Ϫ . The Cl Ϫ -dependent K ϩ flux (KCC3 activity) was defined as the efflux difference between Cl Ϫ and NO 3 Ϫ (or CH3OSO 3 Ϫ media.
Each value represents mean Ϯ SEM (n ϭ 6). 
There is no significant difference in cell size between these cell lines (Fig. 2B) .
Further experiments were performed to look at aspects of KCC3 regulation and to confirm that KCC3 is a KCl cotransporter. (Fig. 3 B and C) . On the other hand, the Cl Ϫ efflux was not sensitive to either DIOA or NEM in parental and mocktransfected cells (data not shown). These results establish that KCC3 functions as a KCl cotransporter. To investigate the drug effects on K ϩ efflux, KCC3-transfected cells were preincubated with 0.05% DMSO (control group) or drugs for 15 min at room temperature and then exposed to flux medium in the presence or absence of drugs. Each bar represents mean Ϯ SEM (n ϭ 6). * , P Ͻ 0.05; ** , P Ͻ 0.01; *** , P Ͻ 0.005 compared with control group. One of the most significant functions for KCC is to promote the regulation of cell volume (1-3). Osmotic swelling is therefore one of the important mechanisms shown to control the activity of KCC1 as well as KCC4 (4, 10) . To assess the KCC3 activity challenged by osmotic stress, we investigated the effect of osmotic gradient on the O-and B-insensitive Cl Ϫ -dependent K ϩ efflux. As shown in Fig. 4A , the total K ϩ efflux was proportionally increased at lower osmolalities, but the Cl Ϫ -dependent component of K ϩ efflux was refractory to osmotic swelling. Further, the process of regulatory volume decrease was insensitive to 20 M DIOA (Fig. 4B) . Thus KCC3 did not participate in volume regulation of these cells. This is a significant functional difference between KCC3 and other KCC isoforms.
As shown in Fig. 4C , 1 M staurosporine did not activate KCC3 activity significantly. However, KCC3 activity, measured at increasing staurosporine concentrations, increased by 78 and 150% at 5 and 10 M staurosporine treatment, respectively (Fig.  4C) . KCC3 activity was inhibited by tyrosine kinase inhibitors genistein and herbimycin A and potentiated by tyrosine phosphatase inhibitor Na 3 VO 4 (Fig. 4C) . This indicates that tyrosine phosphorylation is involved in KCC3 regulation.
The obvious question to be answered is ''what is the physiological significance of KCC3?'' because KCC3 has been reported to have a broad distribution among tissues (7) (8) (9) . The physiological mechanisms involved in ion homeostasis may have broader roles in phenomena such as cell proliferation and cell death (21) . We have shown previously that human cervical carcinogenesis was accompanied by a pronounced up-regulation of KCC3 expression (15) . In vascular endothelial cells, the expression of KCC3 mRNA was up-regulated by vascular endothelial growth factor (7). We therefore proposed that changes in KCC3 expression might contribute to cell growth or pathological conditions in cell proliferation. Accordingly, the effect of KCC3 overexpression on cell proliferation was studied. Compared with parental or mock-transfected cells, KCC3 expression enhanced cell growth that could be abolished by KCC inhibitor 20 M DIOA (Fig. 5A ). In the KCC3-transfected cells, the KCC3 activity could be completely inhibited by this concentration of DIOA (Fig. 2 A) . On the other hand, DIOA showed no effect on the growth curves of parental or mock-transfected cells, because there was no endogenous KCC activity in these cells (Figs. 1 and  3A) . Importantly, the viability of these various cell types under different treatments was unimpaired (Fig. 5B ). This indicates that the effect of DIOA is specific and is not caused by an indirect toxic effect.
A reduction in [Cl Ϫ ] i has been reported to activate Na (20) . To rule out the possibility that the advantage of KCC3-transfected cells in proliferation is because of NKCC activation, we test the effect of B on cell growth. As shown in Fig. 5A , the growth curve of KCC3-transfected cells was insensitive to 1 M B, a concentration, which could inhibit 40-50% NKCC activity (20) .
We investigated further whether the inhibitory effect of DIOA on cell growth was because of a block in the progression of cell cycle. FACS measurements showed that 33 Ϯ 1% (n ϭ 5) of KCC3-transfected cells were in G 2 ͞M phase under normal culture conditions for 3 days. In contrast, in the presence of 20 M DIOA for 3 days, only 15 Ϯ 2% (n ϭ 5) of KCC3-transfected cells were in G 2 ͞M (P Ͻ 0.01; Fig. 5 C and D) . More importantly, the phosphorylation of Rb and cdc2 kinase, two key regulators controlling progression through the restriction point from G 1 into S phase and from G 2 into M phase, respectively, was affected by the pharmacological blockade of KCC3. As depicted in Fig.  6 A and B, treatment with 20 M DIOA for 3 days decreased the phosphorylated active form of Rb and increased the phosphorylated inactive form of cdc2 kinase in KCC3-transfected cells. On the other hand, the phosphorylation of Rb and cdc2 kinase was insensitive to DIOA treatment in mock-transfected cells (Fig. 6  C and D) . Thus these results suggest that KCC3 activity is important for the progression of the cell cycle clock.
However, results based on the mere up-regulation in cell proliferation can be taken, at best, as suggestive but not as conclusive evidence for a role of this transporter in cell proliferation. Hence, we studied KCC3 activity under various culture conditions to test whether KCC3 activity is regulated by specific growth factors or cytokines. As shown in Fig. 7A , insulin-like growth factor-1 (IGF-1) stimulated KCC3 activity dose dependently, whereas tumor necrotic factor-␣ (TNF-␣) inhibited KCC3 activity dose dependently when KCC3-transfected cells were treated with IGF-1 or TNF-␣ for 24 h in serum-free medium. Consistently, the expression of KCC3 mRNA was up-regulated by IGF-1 and down-regulated by TNF-␣ (Fig. 7B) . TNF-␣ also induced growth arrest in KCC3-transfected cells but had no effect on the growth pattern of mock-transfected cells (Fig. 7 C and D) . Although IGF-1 stimulated the growth of mock-transfected cells, the proliferation of KCC3-transfected cells was more sensitive to IGF-1 stimulation (Fig. 7 C and D) . However, KCC3 activity was insensitive to the following treatments: (i) serum starvation for 24 h; (ii) oncogenic Ha-ras overexpression induced by IPTG; (iii) incubation with transforming growth factor or epidermal growth factor for 24 h (Fig. 7A) .
Discussion
The KCCs are members of the cation-chloride cotransporter gene family and fall into two phylogenetic subgroups: KCC1 paired with KCC3 and KCC2 paired with KCC4 (10) . In the present study, we establish the functional and pharmacological characterizations of the recently cloned human KCC3 (8) by using the NIH͞3T3 fibroblast expression system. KCC3 shares some common characteristics with other KCC isoforms, e.g., activity is stimulated by NEM and inhibited by DIOA. Despite 75-77% homology to KCC1 (7, 8) , the regulation and function of KCC3 and KCC1 are very different. For example, KCC1 plays a dominant role in regulatory volume decrease in erythrocytes and some epithelial cells (1-3, 15 ), but KCC3 does not contribute to cell volume regulation. Staurosporine, a protein kinase inhibitor of high potency and broad specificity, is reported to stimulate KCC activity in various cell types (8, 22) . For example, the half-maximum stimulatory concentration of staurosporine is about 0.5 M to activate KCC1 in human erythrocytes (23) . However, 2 M staurosporine did not activate KCC1 activity in HEK-293 cells transfected with full-length rabbit KCC1 (24) . In KCC3-transfected HEK-293 cells, 5 M staurosporine gave a 3-fold stimulation in KCC3 activity (8) . Compared with KCC1 in human erythrocytes (23) and KCC3 in HEK-293 cells (8) , the staurosporine effect was much attenuated in our model. The present study also shows that tyrosine phosphorylation is involved in the regulation of KCC3 activity. Fgr and Hck, two members of the Src family of tyrosine kinases, have been proposed to be involved in the regulation of KCC1 in red blood cells (25) , but the physiological input to these tyrosine kinases on KCC3 regulation is unknown. Recently, it has been shown that protein kinase G can regulate KCC3 expression in primary cultures of rat vascular smooth muscle cells (26) .
The present study demonstrates the function of KCC3 in cell proliferation. KCC3 expression enhances cell growth, and this proliferative advantage can be antagonized by pharmacological blockade of KCC3 activity. In red blood cells, 20 M DIOA inhibits KCC and has no effect on NKCC activity (27) . However, it inhibited both KCC and NKCC in HEK cells (20) . Here we demonstrated 1 M B, a concentration sufficient to inhibit 40-50% NKCC activity, did not affect the growth curve of KCC3 transfected cells. This indicates the growth advantage of KCC3-transfected cells is not because of lower [Cl Ϫ ] i , which would activate NKCC. Therefore, the present observation is a specific inhibitory effect of DIOA on KCC3 function rather than the result of nonspecific inhibition of other ion transporters. More importantly, the pharmacological inhibition of KCC3 activity by DIOA induced a significant decrease of cell numbers in the proliferative phase as shown by FACS measurements. It is likely that KCC3 activity is important for cell cycle progression. The core components controlling cell cycle progression are various specific cyclin-dependent kinases (cdks) and the kinase regulatory subunits, the cyclins. The role of each cyclin is to activate a specific cdk and direct the activated kinase complex to the appropriate substrate. The activated substrates (e.g., phosphorylated Rb and dephosphorylated cdc2) then execute the key steps in cell cycle progression. KCC activity may affect intracellular K ϩ and Cl Ϫ levels in many cell types (1-3) . Here we found that [Cl Ϫ ] i was 9 mM lower than control in KCC3 transfected cells, which was consistent with the direction of net Cl Ϫ transport through KCC. We therefore propose that the activation of specific cyclin-dependent kinases may be ion-sensitive and is linked with the KCC3 activity. This hypothesis is supported by the results of Western blot analysis for cell cycle proteins. The phosphorylated forms of two key cell cycle regulators, Rb and cdc2 kinase, were significantly changed by the pharmacological blockade of KCC3 activity by DIOA in KCC3-transfected cells. On the other hand, the phosphorylation of Rb and cdc2 kinase was insensitive to DIOA in the mock-transfected cells.
The present study also shows that IGF-1 up-regulates KCC3 mRNA expression, stimulates KCC3 activity, and enhances cell growth. On the other hand, TNF-␣ down-regulates KCC3 mRNA expression, inhibits KCC3 activity, and causes growth arrest. In human endothelial cells, mRNA of KCC3 could be up-regulated by vascular endothelial growth factor and downregulated by TNF-␣ (7). This evidence supports the notion that the activity of KCC3 is sensitive to specific growth factors and cytokines, and this sensitivity is directly associated with cell growth. Because KCC3 is not universally expressed in all cell types, KCC3 cannot be essential for the growth process. However, it is very likely to be important in most epithelia under normal or pathophysiological growth conditions.
In conclusion, this study demonstrates that KCC3 plays a regulatory role in promoting cell growth instead of showing the classical KCC function in cell volume regulation.
